ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,974.07
      0.73%
      US Tech 100
      20,896.00
      0.72%
      Dow Jones
      42,906.95
      0.16%
      Brent Oil
      72.70
      0.00%
      Bitcoin
      94,466.19
      -0.23%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Anebulo Pharmaceuticals Inc (ANEB) Quote

      Anebulo Pharmaceuticals Inc

      Anebulo Pharmaceuticals Inc (ANEB)

      NASDAQ
      1.25
      0.26
      (26.26%)
      At close: December 23 4:00PM
      Delayed by 15 minutes
      1.0201
      -0.2299
      ( -18.39% )
      After Hours: 6:55PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.0201
      Bid
      1.06
      Ask
      1.23
      Volume
      546,480
      0.91 Day's Range 1.35
      0.8001 52 Week Range 3.30
      Market Cap
      26.454M
      Previous Close
      0.99
      Open
      1.0008
      Last Trade
      2546
      @
      1.0201
      (formt)
      Last Trade Time
      17:13:16
      Financial Volume
      $ 595,943
      VWAP
      1.0905
      Average Volume (3m)
      10,209
      Shares Outstanding
      25,933,217
      Dividend Yield
      -
      PE Ratio
      -3.95
      Earnings Per Share (EPS)
      -0.32
      Revenue
      -
      Net Profit
      -8.2M

      About Anebulo Pharmaceuticals Inc

      Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.anebulo.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was $0.99. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of $ 0.8001 to $ 3.30.

      Anebulo Pharmaceuticals currently has 25,933,217 shares outstanding. The market capitalization of Anebulo Pharmaceuticals is $25.67 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.95.

      Ask ADVFN Intelligence (AI)

      ANEB Latest News

      More News

      Form 8-K - Current report

      3 hours ago
      Edgar (US Regulatory)

      Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

      Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

      11 hours ago
      Business Wire

      Form 8-K - Current report

      November 13 2024
      Edgar (US Regulatory)

      Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

      Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...

      November 13 2024
      Business Wire

      Form 8-K - Current report

      October 17 2024
      Edgar (US Regulatory)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

      September 25 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      September 25 2024
      Edgar (US Regulatory)

      Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

      Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

      September 25 2024
      Business Wire

      Form 8-K - Current report

      July 22 2024
      Edgar (US Regulatory)

      Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

      Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

      July 22 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.4199-29.15972222221.441.440.8001502791.09133785CS
      4-0.4599-31.07432432431.481.650.8001194251.19808959CS
      12-1.0899-51.6540284362.112.140.8001102091.41436473CS
      26-1.7199-62.77007299272.743.080.800190341.86059929CS
      52-1.4699-59.03212851412.493.30.800180092.16260551CS
      156-5.3499-83.98587127166.377.8850.800187723.04812756CS
      260-6.3599-86.17750677517.389.330.8001100704.22010823CS

      ANEB - Frequently Asked Questions (FAQ)

      What is the current Anebulo Pharmaceuticals share price?
      The current share price of Anebulo Pharmaceuticals is $ 1.0201
      How many Anebulo Pharmaceuticals shares are in issue?
      Anebulo Pharmaceuticals has 25,933,217 shares in issue
      What is the market cap of Anebulo Pharmaceuticals?
      The market capitalisation of Anebulo Pharmaceuticals is USD 25.67M
      What is the 1 year trading range for Anebulo Pharmaceuticals share price?
      Anebulo Pharmaceuticals has traded in the range of $ 0.8001 to $ 3.30 during the past year
      What is the PE ratio of Anebulo Pharmaceuticals?
      The price to earnings ratio of Anebulo Pharmaceuticals is -3.95
      What is the reporting currency for Anebulo Pharmaceuticals?
      Anebulo Pharmaceuticals reports financial results in USD
      What is the latest annual profit for Anebulo Pharmaceuticals?
      The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M
      What is the registered address of Anebulo Pharmaceuticals?
      The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904
      What is the Anebulo Pharmaceuticals website address?
      The website address for Anebulo Pharmaceuticals is www.anebulo.com
      Which industry sector does Anebulo Pharmaceuticals operate in?
      Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CREVCarbon Revolution Public Ltd
      $ 8.75
      (124.94%)
      		840.53k
      NCRANocera Inc
      $ 1.43
      (60.58%)
      		3.74M
      BNOXBionomics Ltd
      $ 0.3994
      (57.80%)
      		6.45M
      MYNAMynaric AG
      $ 0.6492
      (47.67%)
      		6.92M
      TIVCTivic Health Systems Inc
      $ 0.3062
      (36.45%)
      		6.74M
      SLGLSol Gel Technologies Ltd
      $ 1.14
      (-30.91%)
      		3.69M
      ANEBAnebulo Pharmaceuticals Inc
      $ 1.0201
      (-18.39%)
      		2.65k
      AIEVThunder Power Holdings Inc
      $ 0.2851
      (-13.34%)
      		37.21k
      TAOPTaoping Inc BVI
      $ 0.37
      (-11.90%)
      		188.12k
      VIVKVivakor Inc
      $ 1.16
      (-11.45%)
      		240
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.426
      (5.68%)
      		14.95M
      DRCTDirect Digital Holdings Inc
      $ 6.66
      (21.09%)
      		13.12M
      MYNAMynaric AG
      $ 0.6492
      (47.67%)
      		6.92M
      TIVCTivic Health Systems Inc
      $ 0.3062
      (36.45%)
      		6.74M
      BNOXBionomics Ltd
      $ 0.3994
      (57.80%)
      		6.45M

      Discussion

      View Full Feed
      10thMountain 10thMountain 2 minutes ago
      Thanks
      HLLK
      jxyzobrien jxyzobrien 2 minutes ago
      trading rules today
      since its value area trading
      buy value low
      short va high

      https://investorshub.advfn.com/uimage/uploads/2024/12/23/jfxayes_dec23.png
      jxyzobrien jxyzobrien 3 minutes ago
      trading rules today
      since its value area trading
      buy value low
      short va high
      weedtrader420 weedtrader420 3 minutes ago
      I’m going to keep buying HBAR as long as it’s under $.30 Thanks for the heads up🙃😁 Blinded By The LITE
      HBARUSD
      DiscoverGold DiscoverGold 4 minutes ago
      $NDX - Probably made a daily cycle low on Friday that was day 35 of the last daily cycle...
      By: CyclesFan | December 23, 2024

      • $NDX - Probably made a daily cycle low on Friday that was day 35 of the last daily cycle. Today it closed above the 20 day MA which is a bullish
      NDX
      Ecomike Ecomike 4 minutes ago
      Time to up the anti with an SEC report, that's your full of BS, and I will call you out.

      https://www.sec.gov/comments/s7-29-22/s72922-20153799-321641.pdf

      It seems I have the trump card.

      Illegal naked shorting and stock manipulation are two of Wall Street
      SAPX
      DrivenByPain DrivenByPain 5 minutes ago
      Dr Sue Xu 3 weeks ago ! https://www.youtube.com/watch?v=8PwCq4csbcA
      SGDH
      CatfishHunter CatfishHunter 5 minutes ago
      Brilliant strategy by Dr. Korenko for starting trials in India with treatment of lymph nodes.  Using the initial safety data from the 5 patients to shore up the IDE submission.  Pretty much locks in IDE approval now. Shouldn't take long for data write up and inclusion into the IDE submission.  
      RDGL
      Jay_B Jay_B 5 minutes ago
      Sadly, I think we have already seen what happenes here.

      They tricked us, bailed out the previous CEO and his noteholders, then poured gasoline on this thing and lit a match, just like Goodfellas.

      Chad is nowhere to be found and has no intention of addressing shareholder
      SFLM
      jcromeenes jcromeenes 6 minutes ago
      I used to be a field consultant and travelled to lots of different construction sites. Besides the foreman and managers, I was a rare species - I spoke English.
      FNMA
      band aid band aid 6 minutes ago
      This company has got to go down as one of the worst places to invest 2024. Merry Christmas to all.
      BIEL
      investisseur101 investisseur101 6 minutes ago
      I am agree I'm very happy to have him here, it's always interesting what he has to say.
      HMBL
      BigBang BigBang 6 minutes ago
      You can say that again!
      COOP
      Penny Stocks 2.0 Penny Stocks 2.0 6 minutes ago
      JUBILEE INTEL ANNOUNCES STRATEGIC PARTNERSHIP WITH PERION AND ITS
      EXPANSION INTO EMAIL MARKETING

      Las Vegas, NV (Tuesday, December 23, 2024): Jubilee Intel, a wholly owned subsidiary of

      Hallmark Venture Group, Inc. (OTC: HLLK), is proud to announce a transformativ
      HLLK
      getyourownshares getyourownshares 7 minutes ago
      https://youtu.be/Q_t4YR8oFlc?si=QJ2B7HtAdhfJ5YKM

      CRKN
      jcromeenes jcromeenes 7 minutes ago
      Just hasn't been done in 40 years. If there were huge amounts of homegrown folks with those skillsets, they would be out there. It's going to take time for people to relearn those skills and "stoop" to blue collar skills.
      FNMA
      getmoreshares getmoreshares 8 minutes ago
      don't you understand the difference between a BID and an ASK??????????????
      BCAP
      Hi_Lo Hi_Lo 9 minutes ago
      Not to mention CIVX.

      Some self-proclaimed "expert trader."

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174582628
      CIVX
      BigBang BigBang 9 minutes ago
      I’ve come to the conclusion, a long time ago, that you have no idea what you are talking about. Your post confirms it!
      COOP
      GREGG THE GREEK GREGG THE GREEK 9 minutes ago
      What’s even funnier is the painter tape nonsense.

      As if most of todays volume wasn’t 02 area

      Oh noooo it’s Mr Bill lolol

      MONI
      MONI
      Brapp Brapp 9 minutes ago
      https://www.poten.com/business-intelligence-products/lng-world-markets-featured-article/

      Delfin is not mentioned in Poten's 2025 outlook. I do not have access to the full content.
      TGLO
      getmoreshares getmoreshares 10 minutes ago
      surely they are collecting interest on my money
      BLFR
      Knowledge is King Knowledge is King 10 minutes ago
      Looks like PSIX will be listing on NASDAQ soon, timing unclear at this point


      https://ih.advfn.com/stock-market/USOTC/power-solutions-pk-PSIX/stock-news/95151647/form-8-a12b-registration-of-securities-section
      delerious1 delerious1 10 minutes ago
      Seriously what's not to like....all this in just a few months....c'mon man...and .....getting good grades....😎🔨

      North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California GlobeNewswire Dec. 20, 2024

      North Bay Resources Ann
      NBRI
      gfp927z gfp927z 11 minutes ago
      Moody's -- >>> Everything Warren Buffett & Charlie Munger Ever Said on Moody’s

      Your Recent History

      NASDAQ
      ANEB
      Anebulo Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads